Pure Global Prepares for Release of Additional
Products and add Cultivation and Extraction
TORONTO, Sept. 9, 2019 /CNW/ - Pure Global Cannabis Inc.
(TSX.V: PURE; OTC: PRCNF; FRA: 1QS) ("Pure Global" or
"PURE") an integrated, growth-oriented life sciences and
consumer products cannabis company, through its wholly-owned
subsidiary PureSinse Inc. ("PureSinse" or the
"Company"), a Health Canada licensed producer under The
Cannabis Act, is pleased to announce that it has received approval
from Health Canada for its most recent license amendment request
allowing for the sale of cannabis oil products, including high
cannabidiol ("CBD") and premium craft cultivars that will become
available soon for medical and legal adult patients.
This licensing will allow the Company to significantly expand
its product offerings to the medical and consumer markets with oils
and post-derivative cannabis products, which are seeing growing
demand. Oils and post-derivatives will be deployed throughout the
Company's brand ecosystem, especially as edibles and
post-derivative products regulations come into being this fall.
This will enable the company to significantly expand consumer sales
through higher margin products.
The Company already has prepared oils formulations, as well as
purification, processing, and packaging equipment in place for this
next phase of operations. It has the capacity to purify, formulate,
and process 10 liters of oil per day, 10,000 capsules per hour,
10,000 vape cartridges per hour, and 2,000 oils bottles per hour.
With Health Canada approval for oil sales, the Company can release
its line of extraction-based products which will soon be available
through its PureSinse Medical eCommerce site, as well as legal
retail cannabis stores across Canada. Pure Global had already expanded
production capabilities, anticipating license approval, to include
in-house production of medicated topicals, creams, gels, balms,
lotions, tinctures, sprays, vape pens, oils bottles, and gel
capsules.
This licensing also clears the path for Health Canada approvals
for Phase 2 cultivation and extraction, for which the Company has
already submitted its readiness package and is in final stages of
approvals. With over 80 genetics to choose from, the company is
ready to begin vertically farmed cultivation and scaled extraction
for its branded and for white labeled products.
"This is an important milestone in our company's
history which will significantly expand our product offerings
for the medical and legal adult channels. We will be able to sell
high-margin oils and post-derivative products across all of our
premium brands and will be one of only and handful of Licensed
Producers to be able to do so. Over 50% of medical patients are
looking for post-derivative products as well as those in our target
consumer markets, which we will now be much better able to serve,"
commented Malay Panchal, President and CEO of Pure Global.
About Pure Global Cannabis
Pure Global Cannabis Inc. is an innovation-based cannabis
company led by experienced pharma, biotechnology, horticultural,
and consumer packaged goods (CPG) experts. The company's wholly
owned subsidiary, PureSinse Inc., is a licensed producer under the
Cannabis Act. The company's Brampton campus houses facilities for
vertically farmed cultivation, R&D, extraction, manufacturing,
and distribution. Pure Global will produce branded and
white-labeled cannabis products for the medical, pharmaceutical,
wellness, health & beauty, natural health, food & beverage,
craft, and recreational legal markets with uniquely formulated and
purified concentrates and dried flower. The company is using the
Canadian market as a springboard to develop and manufacture
euGMP-compliant premium quality cannabis products for international
sale and distribution with a goal to become one of the most trusted
premium international cannabis brands.
FORWARD-LOOKING STATEMENTS
This news release contains certain forward-looking statements,
including, but not limited to, statements about Pure Global's
future plans and intentions. Wherever possible, words such as
"may", "will", "should", "could", "expect", "plan", "intend",
"anticipate", "believe", "estimate", "predict" or "potential" or
the negative or other variations of these words, or similar words
or phrases, have been used to identify these forward-looking
statements. These statements reflect management's current beliefs
and are based on information currently available to management as
at the date hereof.
Forward-looking statements involve significant risk,
uncertainties and assumptions. Many factors could cause actual
results, performance or achievements to differ materially from the
results discussed or implied in the forward-looking statements.
These factors should be considered carefully, and readers should
not place undue reliance on the forward-looking statements.
Although the forward-looking statements contained in this news
release are based upon what management believes to be reasonable
assumptions, Pure Global cannot assure readers that actual results
will be consistent with these forward-looking statements. These
forward-looking statements are made as of the date of this news
release, and Pure Global assumes no obligation to update or revise
them to reflect new events or circumstances, except as required by
law.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSXV)
accepts responsibility for the adequacy or accuracy of this
release.
To register to Pure Global's mailing list, please visit
www.pureglobal.com. Follow @pureglobalcanna on Twitter
and Facebook and @pureglobalcannabis on Instagram.
SOURCE Pure Global Cannabis Inc.